Home › Myasthenia Gravis › District of Columbia
Myasthenia Gravis clinical trials in District of Columbia
6 studies for Myasthenia Gravis are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Feasibility of Remote Monitoring of Patients With Myasthenia Gravis
- The George Washington University, Washington D.C.
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07787247Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- The George Washington University Medical Faculty Associates Foggy Bottom South Pavilion, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06463587MuSK Myasthenia 1000 Study
- George Washington University, Washington D.C.
RecruitingObservational study
Ages 7 to 99 · All sexes · Updated Aug 5, 2026 · NCT06259071Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1024, Washington D.C.
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Jul 30, 2026 · NCT07039916PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
- Research Site, Washington D.C.
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Apr 1, 2026 · NCT06607627Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, Washington D.C.
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT04202341From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.